CRDL
Cardiol Therapeutics Inc.
Price Chart
Latest Quote
$1.14
+0.02 (+1.79%)
Current Price
| Previous Close | $1.12 |
| Open | $1.12 |
| Day High | $1.16 |
| Day Low | $1.12 |
| Volume | 312,239 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 121.51M |
| Total Debt | $76K |
| Cash Equivalents | $18.55M |
| Net Income | $-24.24M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $138.52M |
| EPS (TTM) | $-0.25 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $107.20M |
| Income | $-24.24M |
| Book/sh | $0.15 |
| Cash/sh | $0.21 |
| Employees | 18 |
Financial Ratios
| Quick Ratio | 5.01 |
| Current Ratio | 5.55 |
| Debt/Eq | 0.45 |
Returns & Margins
| ROA | -90.92% |
| ROE | -190.18% |
Ownership
| Insider Ownership | 2.27% |
| Institutional Ownership | 26.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -4.90 |
| P/B | 7.73 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $8.55 |
Technical Indicators
| SMA20 | $1.24 |
| SMA50 | $1.67 |
| SMA200 | $1.30 |
| RSI | 28.57 |
| ATR | 0.0617 |
| Shares Float | 91.98M |
| Short Float | 2.59% |
| Short Ratio | 2.51 |
| Volatility | 0.72 |
| Rel Volume | 0.21 |
Performance History
| Week | -0.87% |
| Month | -32.54% |
| Quarter | -0.87% |
| 6 Months | -16.79% |
| YTD | +14.69% |
| Year | -4.20% |
| 3 Years | +65.22% |
| 5 Years | -74.95% |
| 10 Years | -69.54% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $1.14 | 313,800 |
| 2026-10-26 | $1.12 | 580,200 |
| 2026-10-23 | $1.12 | 1,101,800 |
| 2026-10-22 | $1.15 | 449,500 |
| 2026-10-21 | $1.17 | 622,500 |
| 2026-10-20 | $1.15 | 652,100 |
| 2026-10-19 | $1.10 | 639,700 |
| 2026-10-16 | $1.10 | 631,700 |
| 2026-10-15 | $1.15 | 629,100 |
| 2026-10-14 | $1.14 | 829,900 |
| 2026-10-13 | $1.20 | 2,034,200 |
| 2026-10-12 | $1.18 | 1,756,400 |
| 2026-10-09 | $1.23 | 1,262,300 |
| 2026-10-08 | $1.30 | 925,300 |
| 2026-10-07 | $1.32 | 3,751,400 |
| 2026-10-06 | $1.31 | 4,710,400 |
| 2026-10-05 | $1.32 | 2,960,800 |
| 2026-10-02 | $1.41 | 3,590,700 |
| 2026-10-01 | $1.56 | 1,829,000 |
| 2026-09-30 | $1.66 | 461,300 |
| 2026-09-29 | $1.69 | 677,900 |
| 2026-09-28 | $1.69 | 763,600 |
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on CRDL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $24,402,699 | $28,641,174 | $21,180,803 | $29,394,402 |
| Other Income Expense | $-162,830 | $1,710,940 | $-271,113 | $6,519,181 |
| Net Non Operating Interest Income Expense | $516,552 | $848,599 | $1,449,575 | $880,094 |
| Operating Expense | $24,402,699 | $28,641,174 | $21,180,803 | $29,394,402 |
| General And Administrative Expense | $14,361,495 | $18,411,667 | $11,065,754 | $15,910,256 |
| Other Non Operating Income Expenses | - | $20,070 | $106,481 | $116,937 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Net Interest Income | $516,552 | $848,599 | $1,449,575 | $880,094 |
| Interest Income | $516,552 | $848,599 | $1,449,575 | $880,094 |
| Normalized Income | $-23,886,147 | $-27,772,505 | $-19,624,746 | $-28,397,371 |
| Net Income From Continuing And Discontinued Operation | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Net Income Common Stockholders | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Net Income | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Net Income Including Noncontrolling Interests | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Net Income Continuous Operations | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Pretax Income | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Interest Income Non Operating | $516,552 | $848,599 | $1,449,575 | $880,094 |
| Operating Income | $-24,402,699 | $-28,641,174 | $-21,180,803 | $-29,394,402 |
| Depreciation Amortization Depletion Income Statement | $72,521 | $265,326 | - | - |
| Depreciation And Amortization In Income Statement | $72,521 | $265,326 | - | - |
| Amortization Of Intangibles Income Statement | $0 | $149,588 | - | - |
| Depreciation Income Statement | $72,521 | $115,738 | - | - |
| Per Share | ||||
| Diluted EPS | $-0.28 | $-0.36 | $-0.31 | $-0.35 |
| Basic EPS | $-0.28 | $-0.36 | $-0.31 | $-0.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-24,167,348 | $-30,066,719 | $-20,626,600 | $-35,640,267 |
| Total Unusual Items | $-162,830 | $1,690,871 | $-377,594 | $6,402,244 |
| Total Unusual Items Excluding Goodwill | $-162,830 | $1,690,871 | $-377,594 | $6,402,244 |
| Reconciled Depreciation | $72,521 | $265,326 | $176,608 | $156,379 |
| EBITDA (Bullshit earnings) | $-24,330,178 | $-28,375,848 | $-21,004,195 | $-29,238,023 |
| EBIT | $-24,402,699 | $-28,641,174 | $-21,180,803 | $-29,394,402 |
| Diluted Average Shares | $61,859,085 | $50,892,625 | $45,840,417 | $44,448,698 |
| Basic Average Shares | $61,859,085 | $50,892,625 | $45,840,417 | $44,448,698 |
| Diluted NI Availto Com Stockholders | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Gain On Sale Of Security | $-162,830 | $1,690,871 | $-377,594 | $6,402,244 |
| Amortization | $0 | $149,588 | - | - |
| Research And Development | $9,968,683 | $9,964,181 | $10,115,048 | $13,484,146 |
| Selling General And Administration | $14,361,495 | $18,411,667 | $11,065,754 | $15,910,256 |
| Other Gand A | $7,802,317 | $9,226,627 | $11,065,754 | $15,910,256 |
| Salaries And Wages | $6,559,178 | $9,185,040 | - | - |
Fetched: 2026-10-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $12,713,044 | $17,584,699 | $19,936,817 | $36,911,492 |
| Total Assets | $16,796,397 | $22,658,667 | $26,098,139 | $44,109,168 |
| Total Non Current Assets | $83,977 | $139,088 | $389,274 | $419,940 |
| Current Assets | $16,712,419 | $22,519,579 | $25,708,865 | $43,689,228 |
| Prepaid Assets | $1,321,928 | $516,629 | $669,470 | $1,058,071 |
| Receivables | $160,850 | $257,153 | $199,020 | $341,473 |
| Other Receivables | $121,222 | $185,781 | $97,513 | $192,195 |
| Accounts Receivable | $39,628 | $71,371 | $101,508 | $149,279 |
| Cash Cash Equivalents And Short Term Investments | $15,229,642 | $21,745,798 | $24,840,375 | $42,289,683 |
| Cash And Cash Equivalents | $15,229,642 | $21,745,798 | $24,840,375 | $42,289,683 |
| Goodwill And Other Intangible Assets | - | $0 | $149,588 | $209,637 |
| Other Intangible Assets | - | - | $149,588 | $209,637 |
| Debt | ||||
| Total Debt | $89,261 | $112,734 | $123,975 | $51,819 |
| Long Term Debt And Capital Lease Obligation | $61,992 | $89,261 | $112,734 | $15,946 |
| Current Debt And Capital Lease Obligation | $27,269 | $23,473 | $11,241 | $35,873 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,083,353 | $5,073,968 | $6,011,734 | $6,988,039 |
| Total Non Current Liabilities Net Minority Interest | $61,992 | $89,261 | $112,734 | $15,946 |
| Current Liabilities | $4,021,361 | $4,984,707 | $5,899,000 | $6,972,093 |
| Other Current Liabilities | $1,520,261 | - | $169,370 | $298,596 |
| Payables And Accrued Expenses | $2,473,831 | $4,961,234 | $5,718,389 | $6,637,623 |
| Equity | ||||
| Common Stock Equity | $12,713,044 | $17,584,699 | $20,086,405 | $37,121,129 |
| Total Equity Gross Minority Interest | $12,713,044 | $17,584,699 | $20,086,405 | $37,121,129 |
| Stockholders Equity | $12,713,044 | $17,584,699 | $20,086,405 | $37,121,129 |
| Retained Earnings | $-151,518,558 | $-127,469,581 | $-101,387,947 | $-81,385,606 |
| Other Equity Interest | - | - | $2,501,594 | $2,501,594 |
| Other | ||||
| Ordinary Shares Number | $71,293,872 | $58,744,171 | $46,472,731 | $45,541,358 |
| Share Issued | $71,293,872 | $58,744,171 | $46,472,731 | $45,541,358 |
| Tangible Book Value | $12,713,044 | $17,584,699 | $19,936,817 | $36,911,492 |
| Invested Capital | $12,713,044 | $17,584,699 | $20,086,405 | $37,121,129 |
| Working Capital | $12,691,058 | $17,534,872 | $19,809,865 | $36,717,135 |
| Capital Lease Obligations | $89,261 | $112,734 | $123,975 | $51,819 |
| Total Capitalization | $12,713,044 | $17,584,699 | $20,086,405 | $37,121,129 |
| Additional Paid In Capital | $20,682,129 | $17,526,871 | $13,359,151 | $11,083,969 |
| Capital Stock | $143,549,473 | $127,527,408 | $105,613,606 | $104,921,171 |
| Common Stock | $143,549,473 | $127,527,408 | $105,613,606 | $104,921,171 |
| Long Term Capital Lease Obligation | $61,992 | $89,261 | $112,734 | $15,946 |
| Current Capital Lease Obligation | $27,269 | $23,473 | $11,241 | $35,873 |
| Net PPE | $83,977 | $139,088 | $239,686 | $210,303 |
| Accumulated Depreciation | $-621,968 | $-549,446 | $-467,028 | $-350,469 |
| Gross PPE | $705,945 | $688,534 | $706,714 | $560,772 |
| Leases | $168,710 | $168,710 | $168,710 | $168,710 |
| Other Properties | $365,648 | $365,648 | $398,967 | $264,663 |
| Machinery Furniture Equipment | $171,588 | $154,177 | $139,037 | $127,398 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-10-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-16,980,717 | $-17,836,200 | $-17,951,824 | $-19,409,816 |
| Operating Activities | ||||
| Operating Cash Flow | $-16,963,306 | $-17,821,061 | $-17,906,091 | $-19,356,689 |
| Cash Flow From Continuing Operating Activities | $-16,963,306 | $-17,821,061 | $-17,906,091 | $-19,356,689 |
| Operating Gains Losses | $-90,810 | $-1,513,420 | $-671,121 | $-5,550,387 |
| Investing Activities | ||||
| Capital Expenditure | $-17,411 | $-15,140 | $-45,733 | $-53,126 |
| Investing Cash Flow | $-17,411 | $-15,140 | $-45,733 | $-53,126 |
| Cash Flow From Continuing Investing Activities | $-17,411 | $-15,140 | $-45,733 | $-53,126 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $11,404,781 | $15,186,196 | $0 | $0 |
| Financing Cash Flow | $11,050,546 | $13,397,573 | $-39,378 | $-38,353 |
| Cash Flow From Continuing Financing Activities | $11,050,546 | $13,397,573 | $-39,378 | $-38,353 |
| Net Other Financing Charges | $-339,220 | $-1,885,318 | - | - |
| Net Common Stock Issuance | $11,404,781 | $15,186,196 | $0 | $0 |
| Common Stock Issuance | $11,404,781 | $15,186,196 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-39,378 | $-29,534 | $-39,378 | $-38,353 |
| End Cash Position | $15,229,642 | $21,745,798 | $24,840,375 | $42,289,683 |
| Beginning Cash Position | $21,745,798 | $24,840,375 | $42,289,683 | $59,661,560 |
| Effect Of Exchange Rate Changes | $-585,985 | $1,344,050 | $541,894 | $2,076,292 |
| Changes In Cash | $-5,930,172 | $-4,438,627 | $-17,991,203 | $-19,448,169 |
| Proceeds From Stock Option Exercised | $24,363 | $126,229 | $0 | $0 |
| Net Issuance Payments Of Debt | $-39,378 | $-29,534 | $-39,378 | $-38,353 |
| Net Long Term Debt Issuance | $-39,378 | $-29,534 | $-39,378 | $-38,353 |
| Long Term Debt Payments | $-39,378 | $-29,534 | $-39,378 | $-38,353 |
| Net PPE Purchase And Sale | $-17,411 | $-15,140 | $-45,733 | $-53,126 |
| Purchase Of PPE | $-17,411 | $-15,140 | $-45,733 | $-53,126 |
| Change In Working Capital | $-521,484 | $-662,446 | $-388,179 | $4,087,477 |
| Change In Payables And Accrued Expense | $187,512 | $-757,155 | $-919,234 | $3,182,084 |
| Change In Prepaid Assets | $-805,299 | $152,841 | $388,602 | $957,354 |
| Change In Receivables | $96,303 | $-58,133 | $142,453 | $-51,961 |
| Changes In Account Receivables | $31,743 | $30,136 | $47,771 | $-102,531 |
| Other Non Cash Items | $15,905 | $18,293 | $23,022 | $380,036 |
| Stock Based Compensation | $7,609,538 | $10,152,822 | $2,955,920 | $3,564,931 |
| Depreciation Amortization Depletion | $72,521 | $265,326 | $176,608 | $156,379 |
| Depreciation And Amortization | $72,521 | $265,326 | $176,608 | $156,379 |
| Amortization Cash Flow | $0 | $149,588 | $60,049 | $60,049 |
| Amortization Of Intangibles | $0 | $149,588 | $60,049 | $60,049 |
| Depreciation | $72,521 | $115,738 | $116,559 | $96,330 |
| Gain Loss On Investment Securities | $-676,795 | $-169,370 | $-129,227 | $-3,474,095 |
| Net Foreign Currency Exchange Gain Loss | $585,985 | $-1,344,050 | $-541,894 | $-2,076,292 |
| Net Income From Continuing Operations | $-24,048,977 | $-26,081,634 | $-20,002,341 | $-21,995,126 |
| Change In Inventory | - | - | $0 | $0 |
Fetched: 2026-10-21